AVE 0.00% 0.2¢ avecho biotechnology limited

NT - no signs of commercial acumen.So in other words - No big...

  1. 5,797 Posts.
    lightbulb Created with Sketch. 736
    NT - no signs of commercial acumen.

    So in other words - No big deals yet = no commercial acumen - I don't think so.

    The company needs to be ready, primed and certain that POH shareholders will benefit utmost from the deals which will eventuate.
    Rushed, premature deals will only hurt our returns.

    I want to see a deal as much as any, but the last thing i want to see is one of our blockbusters given away for short term gains.
    I'm sure poh could have signed an upfront deal with oxy post phase I trials and shown some acumen, but just imagine, the deal post phase III. Which would you prefer ?

    And my worshiping is based on faith.
    Faith in a product that no other company in the world has.
    One that has endless applications and one that has many major players interested.
    My faith requires patience.
    In the mean time, you can jump from share to share making a decent living, but don't cast doubt, just because things don't happen within your trading time lines.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.